API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.biospace.com/article/releases/micurx-reports-positive-top-line-results-of-a-china-phase-3-clinical-trial-for-novel-antibiotic-contezolid-in-complicated-skin-and-soft-tissue-infections/?s=69
https://www.businesswire.com/news/home/20180921005016/en/MicuRx-Announces-Receipt-FDA%E2%80%99s-QIDP-Fast-Track/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==
https://endpts.com/hong-kong-exchange-picks-up-steam-with-two-biotech-ipos-from-innovent-micurx/